Venlafaxine Extended-Release Tablets — Class III drug recall D-0208-2025
Completed recall by Appco Pharma LLC, reported 2025-01-29, distributed nationwide. Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
| Recall number | D-0208-2025 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Completed |
| Voluntary or mandated | Voluntary |
| Recalling firm | Appco Pharma LLC, Piscataway, NJ, United States |
| Recall initiated | 2025-01-16 |
| Classified | 2025-01-23 |
| Reported by FDA | 2025-01-29 |
| Distributed | Nationwide (US) |
| Quantity | 1,380 bottles |
| NDC | 43598-0943, 43598-0943-30, 43598-0943-90, 43598-0944, 43598-0944-30, 43598-0944-90 |
| Lot numbers | 2402101UR |
| Expiration dates | 2027-02-28 |
Product
Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.
Reason for recall
Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0208-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.